Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer.
Rousseau A, Tagliamento M, Auclin E, Aldea M, Frelaut M, Levy A, Benitez JC, Naltet C, Lavaud P, Botticella A, Grecea M, Chaput N, Barlesi F, Planchard D, Besse B.
Rousseau A, et al. Among authors: grecea m.
Eur J Cancer. 2023 Mar;182:107-114. doi: 10.1016/j.ejca.2023.01.007. Epub 2023 Jan 13.
Eur J Cancer. 2023.
PMID: 36758475